To reduce the supply of unapproved, counterfeit, illegal drugs in the U.S.

  • Enhancing the security of the U.S. drug supply chain
  • Taking compliance and enforcement actions
  • Preventing and reducing counterfeit and illegal online sales

United States Government Partners

  • Drug Enforcement Administration (DEA)
  • Customs and Border Protection (CPB)

FDA Activities